A Multicenter Trial of Benefits of Adding Chemotherapy as the Adjuvant Post-surgery Therapy for Cervical Cancer With Adverse Pathological Prognostic Factors
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
distant metastasis free survival,disease free survival
Jihong Liu, Ph.D.
Sun Yat-sen University
China: Ministry of Health